Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects
elderly individuals. Increase in incidence rates in the past decades has been attributed to …

There are several lines of evidence indicating that the physiopathological bases of bullous
pemphigoid (BP), the most common subepidermal autoimmune bullous disease, are …

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder
in the elderly. Systemic and topical use of glucocorticoids and immunosuppressants has …

Subepidermal (subepithelial) autoimmune blistering dermatoses are a group of rare skin
disorders characterized by the disruption of the dermal-epidermal junction through the …

Background Bullous autoimmune dermatoses are a clinically and immunopathologically
heterogeneous group of diseases, characterized clinically by blisters or erosions of the skin …

Bullous pemphigoid (BP) patients are predominantly above 70 years of age, with limited
tolerance to the side effects of the immunosuppressive drugs. Advancements in our …

Bullous pemphigoid (BP), the by far most frequent autoimmune subepidermal blistering
disorder (AIBD), is characterized by the deposition of autoantibodies against BP180 (type …

ABSTRACT Background T-helper 2 (Th2)-associated cytokines are involved in the
pathogenesis of bullous pemphigoid (BP), an autoimmune skin disease. Increased …

Importance The correlation between serum levels of autoantibodies against bullous
pemphigoid (BP) antigens 180 (BP180) and 230 (BP230) with BP disease severity is …

Background Bullous pemphigoid (BP) is the most frequent autoimmune blistering disease
mainly affecting elderly patients. Among several published risk factors, a recent post hoc …